04
2021
Molecular Partners
CEO
Patrick
Amstutz
CFO
Andreas
Emmenegger
ZKB Analyst: Marcel Brand
One-on-one, Small group meeting, Group meeting
Molecular Parnters AG develops and markets biopharmaceutical products. The company develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutict treatments. Molecular Parnters serves healthcare professionals and patients worldwide.